(E)-Fluvoxamine-d4 maleate

• CAT Number: S000399
• CAS Number: 1432075-74-5
• Molecular Formula: C19H21D4F3N2O6
• Molecular Weight: 438.43
• Purity: ≥95%
• IUPAC Name: (Z)-but-2-enedioic acid;1,1,2,2-tetradeuterio-2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine
• InChI: InChI=1S/C15H21F3N2O2.C4H4O4/c1-21-10-3-2-4-14(20-22-11-9-19)12-5-7-13(8-6-12)15(16,17)18;5-3(6)1-2-4(7)8/h5-8H,2-4,9-11,19H2,1H3;1-2H,(H,5,6)(H,7,8)/b20-14+;2-1-/i9D2,11D2
• InChIKey: LFMYNZPAVPMEGP-YNGKOISLSA-N
• SMILES: COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F.C(=CC(=O)O)C(=O)O

(E)-Fluvoxamine-d4 maleate（Cat No.:S000399） is a deuterated version of fluvoxamine maleate, where four hydrogen atoms are replaced with deuterium. This structural change enhances the drug’s stability, facilitating more accurate pharmacokinetic and metabolic studies. Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) commonly prescribed for treating obsessive-compulsive disorder (OCD) and depression. It works by increasing serotonin levels in the brain, which helps regulate mood and behavior. The maleate salt form increases its solubility and bioavailability.